i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i ne...
i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i never left China and i want to go home i hate my parents for bringing me to the USA, i wish i ne...
……describing what has become a part of traditional and new organized crime that is networking through the United States and some other countries.
Organized crime groups
……and “criminal elements” from all walks of life use or hire for pay, criminal organized stalking crews to assault “targets” to cover up financial or other crimes.
These criminals “contract” with the covert organized assault crews:
to silence any potential witness or “trouble maker”, whether real or imagined, that could possibly effect their lives. “contract” / “assault squad” to discredit and silence …………using their criminal “gas-lighting” methods.
These “organized criminal crews“ assault
[victim’s] family, friends, neighbors and many people in community. There is always a reason someone is targeted and most will know why and who started it, but apparently:
some victims never know what happened to them, why it is happening or who “triggered” the over...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
Judged:Brilliant1 I believe that I have discovered Accutane’s mechanism of action and I will lay my evidence on the table and the reader be the judge. This specific information about the mechanism of action might someday lead to a treatment for Accutane induced cellular damage. After all, it’s much more difficult to fix something when you do not know what is wrong. I’ve provided the scientific studies to back up my hypothesis and used analogies in order to make the biological concepts easier to understand. I’ve explained everything in such a way that it’s very straightforward, even for people without a background in molecular biology.
Today, most people that are scientifically savvy about Accutane know that it decreases cell proliferation (in the bone, skin, gut,...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
Thakur listened intently. Kumar had not even gotten to the really bad news. On the plane back to India, his traveling companion, another Ranbaxy executive, confided that the problem was not limited to Vimta or to those ARV drugs.
“What do you mean?” asked Thakur, barely able to grasp what Kumar was saying.
The problem, said Kumar, went deeper. He directed Thakur to put aside his other responsibilities and go through the company’s portfolio — ultimately, every drug, every market, every production line — and uncover the truth about Ranbaxy’s testing practices and where the company’s liabilities lay.
MORE: Maker of generic Lipitor pleads guilty to selling ‘adulterated drugs’
Thakur left Kumar’s office stunned. He returned home that evening to find his 3-year-old son playing on the front lawn. The previous year in India, the boy had developed a serious ear infection. A pediatrician prescribed Ranbaxy’s version of amoxiclav, a powerful antibiotic. For three scary days, his son’s 102°...
FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.
His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.
Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then ...
Thakur listened intently. Kumar had not even gotten to the really bad news. On the plane back to India, his traveling companion, another Ranbaxy executive, confided that the problem was not limited to Vimta or to those ARV drugs.
“What do you mean?” asked Thakur, barely able to grasp what Kumar was saying.
The problem, said Kumar, went deeper. He directed Thakur to put aside his other responsibilities and go through the company’s portfolio — ultimately, every drug, every market, every production line — and uncover the truth about Ranbaxy’s testing practices and where the company’s liabilities lay.
MORE: Maker of generic Lipitor pleads guilty to selling ‘adulterated drugs’
Thakur left Kumar’s office stunned. He returned home that evening to find his 3-year-old son playing on the front lawn. The previous year in India, the boy had developed a serious ear infection. A pediatrician prescribed Ranbaxy’s version of amoxiclav, a powerful antibiotic. For three scary days, his son’s 102...
Homepage CryptoMedication Follow Sign inGet started HOMEANNOUNCEMENTSNEWSPRICE ANALYSISCOIN REVIEWSTECH. ANALYSISICOSBLOCKCHAINPATREON Go to the profile of CryptoMedication CryptoMedicationFollow #DYOR Ph.D in Googling Shit Up |Telegram - http://t.me/CoinEducation | http://www.medium.com/@cryptomeds | Journalist for @btc_manager | Not a Financial Advisor May 16· Uncovering the Real Cartel in Bitcoin
Disclaimer: Consider everything you read here to be an opinion that I have formed based on what I have observed and researched personally. These are merely the associations and relationships that I have found and all inferences and insinuations are explicitly my opinion based on the deductiv...
post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to memo.cash!post to...
This is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a mssive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETUR...
This is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETURNThis is a massive OP_RETU...